Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: The Adjuvant Clinical Trial Populations Explained Authors: Erika Hamilton, MD; Nadia Harbeck, MD, PhD

https://www.medscape.org/viewarticle/1002403?sso=true&uac=148436CN&src=mkmcmr_driv_stan_mscpedu_250708-OUS-HONC-1002403-cta